- What is Atlanta Braves Holdings, Inc. Series A Common Stock's Market Cap?
- Atlanta Braves Holdings, Inc. Series A Common Stock's Market Cap is $3.6B, based on as-reported figures from SEC (XBRL) filings.
- What is Atlanta Braves Holdings, Inc. Series A Common Stock's Enterprise Value?
- Atlanta Braves Holdings, Inc. Series A Common Stock's Enterprise Value is $4.3B, based on as-reported figures from SEC (XBRL) filings.
- What is Atlanta Braves Holdings, Inc. Series A Common Stock's Price / Sales?
- Atlanta Braves Holdings, Inc. Series A Common Stock's Price / Sales is 4.8×, based on as-reported figures from SEC (XBRL) filings.
- What is Atlanta Braves Holdings, Inc. Series A Common Stock's EV / Revenue?
- Atlanta Braves Holdings, Inc. Series A Common Stock's EV / Revenue is 5.8×, based on as-reported figures from SEC (XBRL) filings.
- What is Atlanta Braves Holdings, Inc. Series A Common Stock's EV / EBITDA?
- Atlanta Braves Holdings, Inc. Series A Common Stock's EV / EBITDA is 367.3×, based on as-reported figures from SEC (XBRL) filings.
- What is Atlanta Braves Holdings, Inc. Series A Common Stock's Revenue (TTM)?
- Atlanta Braves Holdings, Inc. Series A Common Stock's Revenue (TTM) is $750.0M, based on as-reported figures from SEC (XBRL) filings.
- What is Atlanta Braves Holdings, Inc. Series A Common Stock's Net Income (TTM)?
- Atlanta Braves Holdings, Inc. Series A Common Stock's Net Income (TTM) is -$64.2M, based on as-reported figures from SEC (XBRL) filings.
- What is Atlanta Braves Holdings, Inc. Series A Common Stock's EBITDA?
- Atlanta Braves Holdings, Inc. Series A Common Stock's EBITDA is $11.1M, based on as-reported figures from SEC (XBRL) filings.
- What is Atlanta Braves Holdings, Inc. Series A Common Stock's Diluted EPS (TTM)?
- Atlanta Braves Holdings, Inc. Series A Common Stock's Diluted EPS (TTM) is -1.00, based on as-reported figures from SEC (XBRL) filings.
- What is Atlanta Braves Holdings, Inc. Series A Common Stock's EBITDA Margin?
- Atlanta Braves Holdings, Inc. Series A Common Stock's EBITDA Margin is 1.5%, based on as-reported figures from SEC (XBRL) filings.